| NCT06833931 | A Study of PGN-EDO51 or Placebo in People With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment | WITHDRAWN | PHASE2 | 2024-12-17 | 2025-05-28 | 2025-05-28 |
| NCT06667453 | A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 | RECRUITING | PHASE2 | 2024-12-10 | 2026-08 | 2026-08 |
| NCT06079736 | A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment | TERMINATED | PHASE2 | 2024-01-08 | 2025-08-28 | 2025-08-28 |
| NCT06204809 | Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1 | ACTIVE_NOT_RECRUITING | PHASE1 | 2023-12-12 | 2025-10 | 2025-10 |